Cargando…
Novel Dimer Derivatives of PF-543 as Potential Antitumor Agents for the Treatment of Non-Small Cell Lung Cancer
Lung cancer can be divided into non-small cell lung cancer (NSCLC) and small cell lung cancer, and the incidence and mortality rate are continuously increasing. In many cases, lung cancer cannot be completely treated with surgery, so chemotherapy is used in parallel; however, the treatment often fai...
Autores principales: | Kim, Su Bin, Limbu, Khem Raj, Oh, Yoon Sin, Kim, Soo Lim, Park, Seung Ki, Baek, Dong Jae, Park, Eun-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611471/ https://www.ncbi.nlm.nih.gov/pubmed/36297469 http://dx.doi.org/10.3390/pharmaceutics14102035 |
Ejemplares similares
-
Synthesis and Biological Evaluation of BODIPY-PF-543
por: Shrestha, Jitendra, et al.
Publicado: (2019) -
Synthesis of PP2A-Activating PF-543 Derivatives and Investigation of Their Inhibitory Effects on Pancreatic Cancer Cells
por: Kim, Su Bin, et al.
Publicado: (2022) -
Verification of the Necessity of the Tolyl Group of PF-543 for Sphingosine Kinase 1 Inhibitory Activity
por: Kim, Su Bin, et al.
Publicado: (2020) -
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway
por: Limbu, Khem Raj, et al.
Publicado: (2022) -
Induction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells
por: Hamada, Masakazu, et al.
Publicado: (2017)